参考文献/References:
[1] Huang MX, Nichols S, Baker DG, et al. Single-subject-based whole-brain MEG slow-wave imaging approach for detecting abnor-mality in patients with mild traumatic brain injury[J]. Neuroimage Clin, 2014, 5:109-119.
[2] Jeyaraj JA, Clendenning A, Bellemare-Lapierre V, et al. Clini-cians’ perceptions of factors contributing to complexity and inten-sity of care of outpatients with traumatic brain injury[J]. Brain Inj, 2013, 27(12):1338-1347.
[3] Vasterling JJ, Brailey K, Proctor SP, et al. Neuropsychological out-comes of mild traumatic brain injury, post-traumatic stress disorder and depression in Iraq-deployed US Army soldiers[J]. Br J Psychia-try, 2012, 201(3):186-192.
[4] Ilie G, Boak A, Adlaf EM, et al. Prevalence and correlates of trau-matic brain injuries among adolescents[J]. JAMA, 2013, 309(24):2550-2552.
[5] Rockhill CM, Jaffe K, Zhou C, et al. Health care costs associated with traumatic brain injury and psychiatric illness in adults[J]. J Neurotrauma, 2012, 29(6):1038-1046.
[6] Taylor HG, Dietrich A, Nuss K, et al. Post-concussive symptoms inchildren with mild traumatic brain injury[J]. Neuropsychology, 2010, 24(2):148-159.
[7] Bigler ED. Neuroimaging biomarkers in mild traumatic brain injury(mTBI)[J]. Neuropsychol Rev, 2013, 23(3):169-209.
[8] Bombardier CH, Fann JR, Temkin NR, et al. Rates of major de-pressive disorder and clinical outcomes following traumatic brain injury[J]. JAMA, 2010, 303(19):1938-1945.
[9] Hart T, Hoffman JM, Pretz C, et al. A longitudinal study of major and minor depression following traumatic brain injury[J]. Arch Phys Med Rehabil, 2012, 93(8):1343-1349.
[10] McMahon P, Hricik A, Yue JK, et al. Symptomatology and func-tional outcome in mild traumatic brain injury:results from the prospective TRACK-TBI study[J]. J Neurotrauma, 2014, 31(1):26-33.
[11] Umile EM, Sandel ME, Alavi A, et al. Dynamic imaging in mild traumatic brain injury:support for the theory of medial temporal vulnerability[J]. Arch Phys Med Rehabil, 2002, 83(11):1506-1513.
[12] Peskind ER, Petrie EC, Cross DJ, et al. Cerebrocerebellar hy-pometabolism associated with repetitive blas texposure mild trau-matic brain injury in 12 Iraq war Veterans with persistent post-con-cussive symptoms[J]. Neuroimage, 2011, 54 Suppl1:S76-82.
[13] Byrnes KR, Wilson CM, Brabazon F, et al. FDG-PET imaging in mild traumatic brain injury:a critical review[J]. Front Neuroener-getics, 2014, 5:13.
[14] Mendez MF, Owens EM, Reza Berenji G, et al. Mild traumatic brain injury from primary blast vs. blunt forces:post-concussion conse-quences and functional neuroimaging[J]. Neuro Rehabilitation, 2013, 32(2):397-407.
[15] Petrie EC, Cross DJ, Yarnykh VL, et al. Neuroimaging, behavioral, and psychological sequelae of repetitive combined blast/impact mild traumatic brain injury in Iraq and Afghanistan war veterans[J]. J Neurotrauma, 2014, 31(5):425-436.
[16] Selwyn R, Hockenbury N, Jaiswal S, et al. Mild traumatic brain in-jury results in depressed cerebral glucose uptake:an FDG PET study[J]. J Neurotrauma, 2013, 30(23):1943-1953.
[17] Diaz-Arrastia R, Kochanek PM, Bergold P, et al. Pharmacotherapy of traumatic brain injury:state of the science and the road forward report of the department of defense neurotrauma pharmacology workgroup[J]. J Neurotrauma, 2014, 31(2):135-158.
[18] Bergsneider M, Hovda DA, McArthur DL, et al. Metabolic recovery following human traumatic brain injury based on FDG-PET:time course and relationship to neurological disability[J]. J Head Trauma Rehabil, 2001, 16(2):135-148.
[19] Provenzano FA, Jordan B, Tikofsky RS, et al. F-18 FDG PET imag-ing of chronic traumatic brain injury in boxers:a statistical para-metric analysis[J]. Nucl Med Commun, 2010, 31(11):952-957.
[20] Garcia-Panach J, Lull N, Lull JJ, et al. A voxel-based analysis of FDG-PET in traumatic brain injury:regional metabolism and rela-tionship between the thalamus and cortical areas[J]. J Neurotrau-ma, 2011, 28(9):1707-1717.
[21] Wu HM, Huang SC, Hattori N, et al. Selective metabolic reduction in gray matter acutely following human traumatic brain injury[J]. J Neurotrauma, 2004, 21(2):149-161.
[22] Xu Y, McArthur DL, Alger JR, et al. Early nonischemic oxidative metabolic dysfunction leads to chronic brain atrophy in traumatic brain injury[J]. J Cereb Blood Flow Metab, 2010, 30(4):883-894.
[23] Wu HM, Huang SC, Vespa P, et al. Redefining the pericontusional penumbra following traumatic brain injury:evidence of deterio-rating metabolic derangements based on positron emission tomogra-phy[J]. J Neurotrauma, 2013, 30(5):352-360.
[24] Cunningham AS, Salvador R, Coles JP, et al. Physiological thresh-olds for irreversible tissue damage in contusional regions following traumatic brain injury[J]. Brain, 2005, 128(Pt 8):1931-1942.
[25] Kawai N, Nakamura T, Tamiya T, et al. Metabolic disturbance without brain ischemia in traumatic brain injury:a positron emis-sion tomography study[J]. Acta Neurochir Suppl, 2008, 102:241-245.
[26] Hattori N, Huang SC, Wu HM, et al. PET investigation of post-trau-matic cerebral blood volume and blood flow[J]. Acta Neurochir Suppl, 2003, 86:49-52.
[27] Rostami E, Engquist H, Enblad P. Imaging of cerebral blood flow in patients with severe traumatic brain injury in the neurointensive care[J]. Front Neurol, 2014, 5:114.
[28] Hamilton JP, Chen MC, Gotlib IH. Neural systems approaches to understanding major depressive disorder:an intrinsic functional organization perspective[J]. Neurobiol Dis, 2013, 52(1):4-11.
[29] Nielsen TH, Bindslev TT, Pedersen SM, et al. Cerebral energy metabolism during induced mitochondrial dysfunction[J]. Acta Anaesthesiol Scand, 2013, 57(2):229-235.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[8]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[9]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[10]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]